House committee investigates FDA approval of Sanofi-Aventis’ Ketek NACDS, GPhA respond with guarded optimism to State of the Union address FDA evaluation of Vytorin study not due until mid-2008 President Bush signs defense act into law; TRICARE access preserved Scott appointed CEO of TargetRx Novo sells programs to TransTech Inverness to acquire Matria for $1.18 billion Supervalu tests pharmacies at front of store GSK drug gets orphan status from FDA Oramed continues trials for oral insulin capsule First Previous 2581 2582 2583 2584 2585 Next Last